#ESHAL2022

Live Conference: March 10-13, 2022 CET
On-Demand Conference: March 1 – April 13, 2022

Dear Colleagues and Friends,

REGISTRATION IS FREE OF CHARGE!
Do not miss this opportunity to share science and education in the field of Acute Leukaemias, and to interact live with global experts directly from your home or office!

An outstanding faculty of distinguished global experts will provide state-of-the-art recommendations regarding patient care and insights into controversies and new therapeutic perspectives in the field.

The plenary E-Conference programme is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, including a maximum level of interaction between faculty and registered participants. Prepare your questions and share in the discussions!

Register to gain full access to the meeting’s scientific content:

• Join the live programme to view the talks according to the Central European Time (CET) schedule and participate in live interactive cases, live debates, roundtable discussions, Live Meet the Expert sessions, interactive live panel discussions, voting and Q&A periods, and Live Mentored Poster Walk.
  See the PDF Live Programme here.
• Also go to the recorded Programme on-demand to view the sessions you may have missed and to revisit those you enjoyed the most, or to view them at your leisure before the live panel discussions.
  The pre-recorded lectures will be available “on-demand” as of March 1st, 2022. The meeting’s full programme, enriched by the many live elements recorded real time, will remain accessible to registered participants for 1 month after the live meeting is over.
• Register for the live Meet the Expert sessions and take the opportunity to receive personal guidance from global experts. Come prepared to turn on your webcam and microphone and to ask questions.
  Space is limited and pre-registration is required. Please note that Meet the Expert sessions do not include a presentation by the session Leaders. They are designed to answer your questions and to provide expert guidance on specific questions. They are open to academic biologists and clinicians only. If you register for one of the sessions you will be expected to come prepared to ask at least one question. Webcam is compulsory.
  Each Meet the Expert session will be organized for a maximum of 25-30 people (extra fee of 20€ per session).
• View the E-Posters and join the interactive Mentored Poster Walk.
• Read the E-Conference E-Book.
• Earn EBAH Continuing Medical Education (CME) credits for the time you spend furthering your knowledge and skills.

And you will:

• Visit the virtual exhibition hall.
• Attend the satellite symposia.

ABOUT THE PROGRAMME:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management which is greatly facilitated by and discussion of real clinical cases.

Novel and still evolving insights into the biology and diagnosis of acute leukaemias, including acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease.

The programme of this “3rd How to Diagnose and Treat: Acute Leukaemias” meeting will integrate of genomic analysis and cutting-edge technics in routine diagnosis, gene mutation-directed therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes.

This meeting will be of interest to:

• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior biologists and clinicians (MD, PhD)
• Clinical residents still in-training
• Allied health care professionals

LEARNING OBJECTIVES:

• Get knowledge of diagnostic tests needed to optimally manage patients with AML and ALL
• Get insight in new treatment strategies available for AML and ALL patients for front-line and for salvage therapy
• Maintenance treatment
• Understand the value of measurable residual disease (MRD) levels to direct acute leukaemia therapy
• Gain insight into emerging mechanisms associated with clinical resistance and leukaemia escape
• Understand the effects and place of new immunotherapies with respect to standard or new HSCT procedures

SCIENTIFIC TOPICS:

• Diagnosis and rare diseases
• Measurable Residual Disease (MRD)
• Leukaemia treatment dilemmas
• Intensive chemotherapy for older fit patients
• MRD level before transplant
• Leukaemia treatment challenges
• Ph-positive ALL
• CAR-T cell for ALL patients
• Immune therapies to treat leukaemia patients
• Haematopoietic stem cell transplantation

Registration is open to healthcare professionals worldwide. The registration is offered for free, as a gesture of solidarity during these difficult times.

Registration includes:
– Access to the programme on-demand on March 1 – April 13, 2022
– Access to the live programme March 10 – 13, 2022 CET
– Access to the Conference E-Book on March 1 – April 13, 2022
– Access to the E-Poster Area from March 1 – April 13, 2022
– Access to the Mentored Poster Walk on March 10, at 19:10 CET
– Certificate of Attendance

Test my connection